3.39
price down icon8.13%   -0.30
after-market Dopo l'orario di chiusura: 3.39
loading

Terns Pharmaceuticals Inc Azioni (TERN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Costs And Expenses
5.77%
25.45
24.06 33.18 21.16 24.16
Operating Income/Loss
5.77%
-25.45
-24.06 -33.18 -21.16 -24.16
Nonoperating Income/Loss
2.66%
3.17
3.088 3.475 3.335 2.689
Income/Loss From Continuing Operations Before Tax
6.23%
-22.28
-20.97 -29.71 -17.82 -21.47
Income Tax Expense/Benefit
97.96%
0.097
0.049 0.058 0.072 0.06
Income/Loss From Continuing Operations After Tax
6.44%
-22.37
-21.02 -29.77 -17.90 -21.53
Net Income/Loss
6.44%
-22.37
-21.02 -29.77 -17.90 -21.53
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
20,457%
74.40
0.3619 71.53 71.36 69.78
Diluted Average Shares
20,457%
74.40
0.3619 71.53 71.36 69.78
Basic Earnings Per Share
3.45%
-0.30
-0.29 -0.42 -0.25 -0.31
Diluted Earnings Per Share
3.45%
-0.30
-0.29 -0.42 -0.25 -0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$310.03
price down icon 3.13%
$19.13
price down icon 7.54%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Capitalizzazione:     |  Volume (24 ore):